abdel kareem azab
University of Texas Southwestern Medical Center
Dallas, United States
Specialty Chief Editor
Anti-Cancer Drugs
- Frontiers in Drug Discovery
- Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
122 editors
Shape the future of research in your field
Join the board
Editors
Specialty Chief Editor
Associate Editors
alma d. campos-parra
Universidad Veracruzana
Xalapa, Mexico
Associate Editor
Anti-Cancer Drugs
zhe-sheng chen
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University
newyork, United States
Associate Editor
Anti-Cancer Drugs
werner j geldenhuys
West Virginia University
Morgantown, United States
Associate Editor
Anti-Cancer Drugs
germain gillet
Université Claude Bernard Lyon 1
Lyon, France
Associate Editor
Anti-Cancer Drugs
greco hernández
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Associate Editor
Anti-Cancer Drugs
syed rashel kabir
University of Rajshahi
Rajshahi, Bangladesh
Associate Editor
Anti-Cancer Drugs
sigrid a langhans
Nemours Children's Health
Wilmington, United States
Associate Editor
Anti-Cancer Drugs
hoang v. le
National Institute on Drug Abuse (NIH)
Bethesda, United States
Associate Editor
Anti-Cancer Drugs
wolfgang link
Spanish National Research Council (CSIC)
Madrid, Spain
Associate Editor
Anti-Cancer Drugs
cristina maccallini
University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Associate Editor
Anti-Cancer Drugs
ross allan mckinnon
Flinders University
Adelaide, Australia
Associate Editor
Anti-Cancer Drugs
thomas miller
Institut Paoli-Calmettes (IPC)
Marseille, France
Associate Editor
Anti-Cancer Drugs
carlos pérez-plasencia
National Autonomous University of Mexico
México City, Mexico
Associate Editor
Anti-Cancer Drugs
des richardson
School of Environment and Science, Griffith Sciences, Griffith University
Nathan, Australia
Associate Editor
Anti-Cancer Drugs
yusuf tutar
University of Health Sciences (Turkey)
Istanbul, Türkiye
Associate Editor
Anti-Cancer Drugs